HOME >> MEDICINE >> NEWS
Newer biomarkers add small improvement in cardiovascular risk prediction to established risk factors

Results of a long-term Framingham Heart Study investigation of multiple biomarkers for the prediction of first major cardiovascular events and death are reported in the December 21 issue of the New England Journal of Medicine (NEJM).

In the study, scientists followed 3209 participants in the Framingham Heart Study for 10 years and measured 10 of the most promising novel biomarkers for predicting the risk of cardiovascular disease (CVD). The newer biomarkers such as natriuretic peptides, C-reactive protein, fibrinogen, urinary albumin, and homocysteine were compared with established risk factors such as high blood pressure, diabetes, and high cholesterol. Measuring several biomarkers simultaneously, referred to as the "multimarker" approach, enabled the scientists to stratify risk. They found that persons with high multimarker scores had a risk of death four times as great and a risk of major cardiovascular events almost two times as great as persons with low multimarker scores. However, the use of multiple biomarkers added only moderately to the overall prediction of risk based on conventional risk factors.

"Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death," was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Daniel Levy, M.D., Director of the Framingham Heart Study, is available to comment on the studys affirmation of the importance of traditional risk factors. He can also discuss the promise of new biomarkers --despite their modest enhancement over conventional risk factors-- in identifying individuals at high risk for cardiovascular events. In addition, Levy can comment on NHLBIs recently announced large-scale biomarker project, a proposed biomarker consortium to conduct research on novel CVD biomarkers and develop new diagnostic tests to identify individuals at high risk for CVD and its risk factors.


'"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
20-Dec-2006


Page: 1

Related medicine news :

1. Newer chemotherapies improve outcomes for some types of breast cancer
2. Newer form of cardiac imaging providing better look at heart
3. Newer diabetic meds cost more, but users have fewer hospital visits
4. Newer imaging techniques may lead to over-treatment
5. Scientists create dual-modality microbeads to improve identification of disease biomarkers
6. Ability of biomarkers to predict risk of heart disease, stroke appears limited
7. Researchers use statistical technique to find mix of biomarkers predicting mortality
8. New biomarkers for improving treatment of spondylarthritis
9. New microchip technology for medical imaging biomarkers of disease
10. Africa: International volunteer impact small, but significant
11. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... 19, 2017 , ... The Semper Fi Fund, one of the nation’s highest-rated ... series of videos and a compelling documentary that provide unique insights and powerful advice ... part of its ongoing mission. , Each of the videos focuses on a specific ...
(Date:9/19/2017)... Montclair, NJ (PRWEB) , ... September 19, 2017 ... ... fall following the success of the annual PAINWeek National Conference. On October 7, ... will be an educational and exciting program providing busy clinicians and allied healthcare ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... board-certified veterinary oncologist, has agreed to serve as strategic adviser to the ... Tripp is founder of the Bridge Animal Referral Center (BARC) in Edmonds, ...
(Date:9/19/2017)... Reno, Nev. (PRWEB) , ... September 19, 2017 ... ... 20 students across the country with the Davidson Fellows Scholarship on September 27 ... awards for projects in Science, Technology, Engineering, Mathematics, Literature and Music. , “I ...
(Date:9/19/2017)... ... September 19, 2017 , ... With Netmail Hadron, ... the United States, can easily manage all of their data, apply policies on ... platforms simultaneously. “As a construction company,” says Ryan Sinnwell, the Infrastructure Manager at ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Del. , Sept. 6, 2017 NeuroRx, a ... Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast ... its sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 ... in a pivotal trial of this sequential therapy targeting patients ... depression. 1 ...
(Date:9/5/2017)... 5, 2017 Sapheneia and Scannerside received FDA ... DoseCheck is a third-party Vendor neutral CT product that ... allows compliance with current MITA standards. ... DoseCheck solution is specifically designed to provide CT operators, ... radiation doses over a predefined threshold. Scannerside Dose Check ...
(Date:9/5/2017)... 2017  Getinge, a leading global provider of ... donation program -- "Color for the Kids!" -- ... research by The Children,s Heart Foundation. Pediatric patients ... are encouraged to download a coloring picture at ... to the gallery on the website. For each ...
Breaking Medicine Technology:
Cached News: